Landing Page

Call Us: (650) 515-1979

Back Acne Laser Study

Do you have BACK ACNE that has not responded to standard medications or creams?

You may be a candidate for our clinical research study! If enrolled, you’ll receive up to $600 in compensation for participation!

For more information, please fill out the form below to be contacted by the Cutera Clinic, or reach us directly at (650) 515-1979 or cuteraclinic@cutera.com.

Complete the Form Below!

The Cutera Clinic will be in touch to assess your acne condition.

First Name *

Last Name *

Email *

Phone Number *

Postal Code *

How did you hear about the Cutera Clinic? *

Notes

Current Photo of Skin

By submitting the image above, you consent to the Cutera Clinic using the image to assess your acne condition for purposes of determining whether you qualify for participation in the treatments.

You can revoke this consent at any time by emailing cuteraclinic@cutera.com, at which time the Cutera Clinic will delete the image you submitted.

This study is IRB approved.

Study Requirements

Ages 16-60
All genders
Not pregnant or breastfeeding
Not participating in another clinical trial

Willing to stop current acne medications for 2 weeks prior to the start of the study
Must be willing to receive up to 3 laser treatments
Must be willing to attend up to 4 on-site follow-up visits
Other criteria may apply

AviClear is a first-of-its-kind laser treatment that specifically targets the source of acne – excess sebum from the sebaceous glands¹

Effective

AviClear treats active inflammatory acne and helps prevent future acne by suppressing the sebaceous glands.²

Safe

AviClear is safe for all skin types and tones, as well as mild, moderate, and severe inflammatory acne.³

What is the Cutera Clinic?

The Cutera Clinic is comprised of expert clinical practitioners who help conduct aesthetic and dermatology-based treatments with medical aesthetic devices manufactured and distributed by Cutera.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships.

References: 1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-485 2. Data on file. Cutera, Inc 3. Data on file. FDA clearance study. Cutera, Inc.

Indications for Use: AviClear is FDA cleared for the long-term treatment of mild to severe inflammatory acne vulgaris. Contraindications: Pregnant patients and patients undergoing treatment for skin cancer. Important Safety Information: The following treatment-related side effects may occur during or after treatment with AviClear: Discomfort, erythema and edema, transient acne flareups, temporary skin dryness, blisters, crusting/Scabbing, hyperpigmentation, skin texture changes, infection, scarring, hypopigmentation and altered hair growth. Warnings: Do not use topical anesthetic with AviClear treatments;do not treat over dysplastic nevi or questionable pigmented lesions; do not treat over or close to tattoos or permanent make-up.

For additional information, contact the Cutera Clinic

Phone: 650-515-1979 | Email: cuteraclinic@cutera.com

3240 Bayshore Blvd. Brisbane, CA 94005